These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27345657)

  • 81. p53 mutations and human papillomavirus infection in oral squamous cell carcinomas: correlation with overall survival.
    Kozomara R; Jović N; Magić Z; Branković-Magić M; Minić V
    J Craniomaxillofac Surg; 2005 Oct; 33(5):342-8. PubMed ID: 16129609
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Correlation of tumor markers p53, bcl-2, CD34, CD44H, CD44v6, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma.
    Spafford MF; Koeppe J; Pan Z; Archer PG; Meyers AD; Franklin WA
    Arch Otolaryngol Head Neck Surg; 1996 Jun; 122(6):627-32. PubMed ID: 8639294
    [TBL] [Abstract][Full Text] [Related]  

  • 83. TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.
    Fountzilas G; Giannoulatou E; Alexopoulou Z; Zagouri F; Timotheadou E; Papadopoulou K; Lakis S; Bobos M; Poulios C; Sotiropoulou M; Lyberopoulou A; Gogas H; Pentheroudakis G; Pectasides D; Koutras A; Christodoulou C; Papandreou C; Samantas E; Papakostas P; Kosmidis P; Bafaloukos D; Karanikiotis C; Dimopoulos MA; Kotoula V
    Oncotarget; 2016 May; 7(22):32731-53. PubMed ID: 27129168
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Relationship between molecular markers and treatment response in a retrospective cohort of Indian patients with primary carcinoma of the larynx.
    Sahoo R; Chittibabu V; Patil G; Rao S; Thakur S; Dhondalay G; Kulkarni AJ; Banerjee A; Ajaikumar BS; Korlimarla A; Nargund A; Niti RN; Gopinath KS; Prabhudesai S; Raghavendra RM
    Oral Oncol; 2009 Dec; 45(12):e216-21. PubMed ID: 19729336
    [TBL] [Abstract][Full Text] [Related]  

  • 85. HPV: a factor in organ preservation for locally advanced larynx and hypopharynx cancer?
    Shaughnessy JN; Farghaly H; Wilson L; Redman R; Potts K; Bumpous J; Silverman C; Dunlap NE
    Am J Otolaryngol; 2014; 35(1):19-24. PubMed ID: 24119488
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Associations of TP53 mutations, codon 72 polymorphism and human papillomavirus in head and neck squamous cell carcinoma patients.
    Shi Q; Xiao K; Wei W; Zhang BY; Chen C; Xu Y; Chen LN; Song YT; Ma X; Zhang NS; Dong XP
    Oncol Rep; 2013 Dec; 30(6):2811-9. PubMed ID: 24064928
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
    Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
    Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
    [TBL] [Abstract][Full Text] [Related]  

  • 88. HPV in Larynx Squamous Cell Carcinoma: New Serotypes and Survival Study within 10-Year Follow-up.
    Sánchez Barrueco A; González Galán F; Lora Pablos D; Villacampa Aubá JM; Ballestín Carcavilla C; Cenjor Español C; Almodóvar Álvarez C
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):677-682. PubMed ID: 28322111
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Active human papillomavirus involvement in Barrett's dysplasia and oesophageal adenocarcinoma is characterized by wild-type p53 and aberrations of the retinoblastoma protein pathway.
    Rajendra S; Yang T; Xuan W; Sharma P; Pavey D; Lee CS; Le S; Collins J; Wang B
    Int J Cancer; 2017 Nov; 141(10):2037-2049. PubMed ID: 28722212
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
    Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
    HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
    Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
    Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 93. TP53 mutations and survival in squamous-cell carcinoma of the head and neck.
    Poeta ML; Manola J; Goldwasser MA; Forastiere A; Benoit N; Califano JA; Ridge JA; Goodwin J; Kenady D; Saunders J; Westra W; Sidransky D; Koch WM
    N Engl J Med; 2007 Dec; 357(25):2552-61. PubMed ID: 18094376
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Human papillomavirus and p53 oncoprotein in verrucous carcinoma of the larynx.
    López-Amado M; García-Caballero T; Lozano-Ramírez A; Labella-Caballero T
    J Laryngol Otol; 1996 Aug; 110(8):742-7. PubMed ID: 8869607
    [TBL] [Abstract][Full Text] [Related]  

  • 95. TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosis.
    Thorlacius S; Thorgilsson B; Björnsson J; Tryggvadottir L; Börresen AL; Ogmundsdottir HM; Eyfjörd JE
    Eur J Cancer; 1995 Oct; 31A(11):1856-61. PubMed ID: 8541113
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status.
    Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH
    BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690
    [TBL] [Abstract][Full Text] [Related]  

  • 97. HPV infection and p16
    Missaoui N; Mestiri S; Bdioui A; Zahmoul T; Hamchi H; Mokni M; Hmissa S
    Pathol Res Pract; 2018 Apr; 214(4):498-506. PubMed ID: 29572122
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
    Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.
    Lapke N; Lu YJ; Liao CT; Lee LY; Lin CY; Wang HM; Ng SH; Chen SJ; Yen TC
    Oncotarget; 2016 Jul; 7(28):44194-44210. PubMed ID: 27283772
    [TBL] [Abstract][Full Text] [Related]  

  • 100. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
    Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.